Oncology Institute Inc/the share price logo

Oncology Institute Inc/the Share Price

NASDAQ: TOI

Small Cap

$2.99

-0.01

(-0.33%)

as on

Oncology Institute Inc/the Stock Performance

as on September 18, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $2.95
    $3.06
    downward going graph

    1.34%

    Downside

    2.34%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.13
    $4.5
    downward going graph

    95.81%

    Downside

    50.50%

    Upside

    downward going graph

Oncology Institute Inc/the share price movements today

Previous Close
$3.00
Open
$2.98
Volume
848.9K
Day's Low - High
$2.95 - $3.06
52 Week Low - High
$0.13 - $4.5

Oncology Institute Inc/the Historical Returns

1 Month Return
-17.02 %
3 Month Return
+ 33.33 %
1 Year Return
+ 975.49 %
3 Year Return
-30.97 %
5 Year Return
0 %

Oncology Institute Inc/the Stock Fundamentals & Key Indicators

Check Oncology Institute Inc/the market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$291.7M

EPS (TTM)

-0.5267

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.4

Industry PE ratio

-3.9281873111782475

P/B Ratio

0

PEG Ratio

0

EBITDA

-40.0M

Revenue (TTM)

424.4M

Profit Margin

-15.53%

Return On Equity TTM

1035700.00%

Oncology Institute Inc/the Stock Valuation

Track how Oncology Institute Inc/the P/E has moved over time to understand its valuation trends.

Oncology Institute Inc/the in the last 5 years

  • Overview

  • Trends

Lowest (0.00x)

September 17, 2025

Industry (-3.93x)

September 17, 2025

Today (-0.40x)

September 17, 2025

Highest (-0.37x)

December 31, 2024

LowHigh

Today’s Price to Earnings Ratio: -0.40x

Oncology Institute Inc/the vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Oncology Institute Inc/the with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$291.7MNA-0.4-15.53%
BUY$16.2B527.1%11.497.18%
BUY$12.5B89.78%24.099.22%
BUY$93.5B191.49%16.788.21%
HOLD$11.9B52.63%9.817.66%

Stock Returns calculator for Oncology Institute Inc/the Stock including INR - Dollar returns

The Oncology Institute Inc/the stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Oncology Institute Inc/the investment value today

Current value as on today

₹10,35,633

Returns

₹9,35,633

(+935.63%)

Returns from Oncology Institute Inc/the Stock

₹9,31,034 (+931.03%)

Dollar Returns*

₹4,598 (+4.6%)

Analyst Recommendation on Oncology Institute Inc/the Stock

Based on 5 analysts

BUY

80.00%

Buy

20.00%

Hold

0.00%

Sell

Based on 5 analysts, 80% of analysts recommend a 'BUY' rating for Oncology Institute Inc/the. Average target price of $7

Oncology Institute Inc/the Share Price Target

Get share price movements and forecasts by analysts on Oncology Institute Inc/the.

What analysts predicted

57.29%UPSIDE

Target Price

$7

Current Price

$2.99

Analyzed by

5 Analysts

Target

$7.00

Oncology Institute Inc/the target price $7, a slight upside of 57.29% compared to current price of $2.99. According to 5 analysts rating.

Oncology Institute Inc/the Stock's Interest Amongst Investors

Search interest for Oncology Institute Inc/the Stock has increased by 1% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:1% versus previous 30 day period

Oncology Institute Inc/the Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
76
80
82
85
94
98
99
100
104
119
Gross Profit
14
15
15
14
11
13
14
14
17
15
Operating Income
-16
-14
-13
-15
-17
-16
-13
-11
-9
-11
EBITDA
-26
-13
-12
-18
-16
-11
-12
-10
-12
-13
Interest Expense
2
2
2
1
1
2
2
1
5
1
Depreciation
1
1
1
1
1
1
1
1
1
1
Income Before Tax
-29
-16
-17
-19
-19
-15
-16
-13
-19
-17
Income Tax Expense
0
0
0
0
0
-2
-
3
-
0
Net Income
-29
-16
-17
-18
-19
-15
-16
-13
-19
-17
Net Profit Margin
-39.37%
-21.06%
-21.23%
-21.86%
-21.01%
-15.70%
-16.13%
-13.15%
-18.76%
-14.20%

Oncology Institute Inc/the Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
113
155
187
203
252
324
393
Gross Profit
26
29
36
40
52
59
53
Operating Income
4
-2
-8
-45
-81
-77
-60
EBITDA
9
0
-11
-7
8
-70
-50
Interest Expense
0
0
0
0
4
6
7
Depreciation
1
2
3
3
4
5
6
Income Before Tax
4
-2
-14
-11
0
-83
-64
Income Tax Expense
0
1
0
0
0
0
-
Net Income
3
-4
-14
-10
0
-83
-64
Net Profit Margin
3.49%
-2.59%
-7.64%
-5.38%
0.06%
-25.62%
-16.44%

Oncology Institute Inc/the Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-16
-17
-18
-19
-15
-16
-13
-19
-17
Operating Cash Flow
-8
-8
-3
-15
-15
0
4
-4
-10
Investing Cash Flow
24
7
11
19
18
10
-1
0
-1
Financing Cash Flow
-2
0
-1
0
-2
0
0
-4
1
Change in Cash
13
-1
5
2
0
10
2
-9
-9

Oncology Institute Inc/the Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-4
-14
-10
1
-83
-64
Operating Cash Flow
3
0
-32
-61
-36
-26
Investing Cash Flow
-1
-8
-12
-131
62
46
Financing Cash Flow
0
11
154
92
-6
-3
Change in Cash
2
3
109
-101
19
16

Global Institutional Holdings in Oncology Institute Inc/the

Funds
Holdings
TIFF Advisory Services Inc
3.95%
Deerfield Management Co
3.66%
Balyasny Asset Management LLC
2.34%
JOSH ARNOLD INVESTMENT CONSULTANT, LLC
2.16%
Vanguard Group Inc
1.9%

Insights on Oncology Institute Inc/the

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, TOI has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, TOI stock has moved up by 934.1%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 18 quarters, 48.58M → 119.80M (in $), with an average increase of 5.1% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -19.58M → -17.00M (in $), with an average increase of 15.1% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Tenet Healthcare Corp.  has given 143.2% return, outperforming this stock by 176.8%

About Oncology Institute Inc/the

the oncology institute of hope and innovation is a premier cancer treatment center in los angeles. offering programs to help patients and families cope with the challenges that are brought on by cancer and strive to optimize their quality of life, comprehensive and realistic treatment goals are tailored to every person's unique needs and decided upon in partnership with the patients and their families. dedicated to excel in cancer prevention, diagnosis and education through our exceptional team of physicians, nurse practitioners, nurses, medical assistants and office staff, the oncology institute of hope and innovation has 8 southern california locations in the cities of downey, long beach, lynwood, montebello whittier, anaheim, la mirada and glendale. for more information please visit www.theoncologyinstitute.com.
OrganisationOncology Institute Inc/the
Headquarters18000 Studebaker Road, Cerritos, CA, United States, 90703
IndustryFinancial
CEODr. Daniel Virnich FACHE, M.B.A., M.D.
E-voting on sharesClick here to vote

Key Management of Oncology Institute Inc/the

Name

Title

Mr. Jordan McInerney

Chief Development Officer

Mr. Stephen Cella

Senior Vice President of Finance

Mr. Austin Lee

VP of Accounting & Controller

Ms. Kristin England

Chief Administrative Officer

Mr. Mark Hueppelsheuser Esq.

General Counsel

Dr. Jeffrey Langsam M.D.

Chief Clinical Officer

Dr. Daniel Virnich FACHE, M.B.A., M.D.

CEO & Executive Director

Dr. Yale D. Podnos F.A.C.S., M.D., M.P.H.

Chief Medical Officer

Mr. Robert Carter

Chief Financial Officer

FAQs

What is Oncology Institute Inc/the share price today?

Oncology Institute Inc/the share price today is $2.99 as on at the close of the market. Oncology Institute Inc/the share today touched a day high of $3.06 and a low of $2.95.

What is the 52 week high and 52 week low for Oncology Institute Inc/the share?

Oncology Institute Inc/the share touched a 52 week high of $4.5 on and a 52 week low of $0.13 on . Oncology Institute Inc/the stock price today i.e. is closed at $2.99,which is 33.56% down from its 52 week high and 2286.27% up from its 52 week low.

What is Oncology Institute Inc/the's market capitalisation today?

Oncology Institute Inc/the market capitalisation is $0.00T as on .

How to invest in Oncology Institute Inc/the Stock (TOI) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Oncology Institute Inc/the on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Oncology Institute Inc/the Shares that will get you 0.5017 shares as per Oncology Institute Inc/the share price of $2.99 per share as on September 18, 2025 at 1:29 am IST.

What is the minimum amount required to buy Oncology Institute Inc/the Stock (TOI) from India?

Indian investors can start investing in Oncology Institute Inc/the (TOI) shares with as little as ₹87.816 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Oncology Institute Inc/the stock (as per the Rupee-Dollar exchange rate as on ). Based on Oncology Institute Inc/the share’s latest price of $2.99 as on September 18, 2025 at 1:29 am IST, you will get 3.3445 shares of Oncology Institute Inc/the. Learn more about fractional shares .